Adjuvant immunotherapy for muscle-invasive urothelial carcinoma: Considerations for targeting patients
{{output}}
While neoadjuvant chemotherapy and radical surgery represent mainstay treatments for muscle-invasive urothelial carcinoma (MIUC), recurrence with lethal metastasis remains high and highlights the need for adjuvant therapies in MIUC, like immunotherapy, already... ...
